FDA Import Refusal SCS-4248193-9/11/7 — Sanofi-Aventis Deutschland GmbH
The FDA refused shipment SCS-4248193-9/11/7 from Sanofi-Aventis Deutschland GmbH (Germany) on Mar 2, 2021. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 2, 2021
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75